New test for coeliac disease could increase diagnosis rates
A new blood test for gluten -specific T cells can detect coeliac disease even without gluten consumption, according to research published in Gastroenterology.
The new blood test could increase diagnosis rates, identify those at risk of severe reactions, and detect silent coeliac disease.
The test measures the immune marker interleukin 2 (IL-2), which spikes in the bloodstream of people with coeliac disease after gluten consumption.
The study showed the test could detect coeliac disease with up to 90 per cent sensitivity and 97 per cent specificity, even in patients on a gluten -free diet.
Researchers are collaborating with Novoviah Pharmaceuticals to confirm the test's accuracy across diverse populations and gather real-world data, potentially leading to faster and safer diagnoses.
'Game-changer' new blood test to detect prevalent autoimmune disease without nightmare side effects
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
25 minutes ago
- Reuters
GSK says EU heath regulator reviewing expansion of RSV vaccine
June 13 (Reuters) - GSK (GSK.L), opens new tab said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its respiratory syncytial virus vaccine, Arexvy, to include adults from 18 years of age. A decision by the European Union's health regulator on the vaccine, already approved for certain age groups, is expected in the first half of 2026, GSK said.
Telegraph
31 minutes ago
- Telegraph
NHS patients to receive drug that destroys cancer from inside
A so-called 'Trojan Horse' drug that destroys blood cancer from within is set to be rolled out to thousands of NHS patients. The health service will be the first in the world to make the drug available to patients with multiple myeloma – an incurable cancer of the bone marrow. The drug, called belantamab mafadotin, was developed in the UK and has been dubbed a 'Trojan Horse' therapy because it tricks cancer cells into absorbing it before killing them from within. While the cancer is incurable, treatment is designed to extend people's lives by as much as possible while minimising the impact of side effects and on quality of life. In trials, cancer progression was delayed by three years on average in those taking the drug, which was three times longer than the most common treatment. Around 1,500 patients a year in England will benefit after the treatment was approved by the National Institute for Health and Care Excellence on Thursday. The drug will be offered to patients whose cancer has progressed or not responded to the first choice of treatment using another drug, lenalidomide. Patients who are prescribed the drug will receive it via an infusion once every three weeks in combination with two other cancer treatments.
BBC News
an hour ago
- BBC News
Kidney Research UK boss appointed OBE at special ceremony
A charity chief executive who has overseen more than £71m being ploughed into research for kidney disease has become an OBE at a special Currie, from Northampton, has been at Peterborough-based Kidney Research UK for more than 12 Wednesday she visited Windsor Castle to be appointed an Officer of the Order of the British Empire (OBE) by the Prince of Wales, which she called a "very special moment".She was recognised in the King's New Year Honours list earlier this year for her services to people affected by the disease. "To represent the kidney community in such a setting was incredibly humbling," she explained. "This honour helps raise the profile of a disease that affects one-in-ten people in the UK, can have devastating consequences for those who reach kidney failure, but is still overlooked. "I'm grateful for the recognition, and more determined than ever to keep pushing for change."There are more than 7.2m people living in the UK with kidney disease, including more than 80,000 in Northamptonshire, the charity Currie has worked to invest millions into research, as well as improve awareness of the disease. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.
